mouse b cells Search Results


mouse b cell isolation kit  (R&D Systems)
92
R&D Systems mouse b cell isolation kit
Mouse B Cell Isolation Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse b cell isolation kit/product/R&D Systems
Average 92 stars, based on 1 article reviews
mouse b cell isolation kit - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
mouse b cell recovery column kit  (Cedarlane)
88
Cedarlane mouse b cell recovery column kit
Mouse B Cell Recovery Column Kit, supplied by Cedarlane, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse b cell recovery column kit/product/Cedarlane
Average 88 stars, based on 1 article reviews
mouse b cell recovery column kit - by Bioz Stars, 2026-05
88/100 stars
  Buy from Supplier
magcellect isolation kit  (R&D Systems)
93
R&D Systems magcellect isolation kit
Magcellect Isolation Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/magcellect isolation kit/product/R&D Systems
Average 93 stars, based on 1 article reviews
magcellect isolation kit - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
rkip  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc rkip
Oxaliplatin (OXP) reduces the phosphorylation <t>of</t> <t>STAT3</t> and <t>RKIP</t> that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.
Rkip, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rkip/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
rkip - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
b cell lymphoma 2  (Cusabio)
93
Cusabio b cell lymphoma 2
Oxaliplatin (OXP) reduces the phosphorylation <t>of</t> <t>STAT3</t> and <t>RKIP</t> that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.
B Cell Lymphoma 2, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b cell lymphoma 2/product/Cusabio
Average 93 stars, based on 1 article reviews
b cell lymphoma 2 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
easyseptm mouse b cell #19854  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc easyseptm mouse b cell #19854
Oxaliplatin (OXP) reduces the phosphorylation <t>of</t> <t>STAT3</t> and <t>RKIP</t> that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.
Easyseptm Mouse B Cell #19854, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easyseptm mouse b cell #19854/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easyseptm mouse b cell #19854 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
easy sep mouse b cell enrichment kit  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc easy sep mouse b cell enrichment kit
Oxaliplatin (OXP) reduces the phosphorylation <t>of</t> <t>STAT3</t> and <t>RKIP</t> that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.
Easy Sep Mouse B Cell Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easy sep mouse b cell enrichment kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easy sep mouse b cell enrichment kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
magcellect tm mouse b cell isolation kit  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc magcellect tm mouse b cell isolation kit
Oxaliplatin (OXP) reduces the phosphorylation <t>of</t> <t>STAT3</t> and <t>RKIP</t> that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.
Magcellect Tm Mouse B Cell Isolation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/magcellect tm mouse b cell isolation kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
magcellect tm mouse b cell isolation kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
biotinylated mouse b cell enrichment cocktail  (Becton Dickinson)
90
Becton Dickinson biotinylated mouse b cell enrichment cocktail
Oxaliplatin (OXP) reduces the phosphorylation <t>of</t> <t>STAT3</t> and <t>RKIP</t> that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.
Biotinylated Mouse B Cell Enrichment Cocktail, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated mouse b cell enrichment cocktail/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
biotinylated mouse b cell enrichment cocktail - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
mouse b cell program  (Lonza)
90
Lonza mouse b cell program
Oxaliplatin (OXP) reduces the phosphorylation <t>of</t> <t>STAT3</t> and <t>RKIP</t> that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.
Mouse B Cell Program, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse b cell program/product/Lonza
Average 90 stars, based on 1 article reviews
mouse b cell program - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
mouse b cell lymphoma p815 transfected with hla-a*0202  (Epimmune Inc)
90
Epimmune Inc mouse b cell lymphoma p815 transfected with hla-a*0202
Oxaliplatin (OXP) reduces the phosphorylation <t>of</t> <t>STAT3</t> and <t>RKIP</t> that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.
Mouse B Cell Lymphoma P815 Transfected With Hla A*0202, supplied by Epimmune Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse b cell lymphoma p815 transfected with hla-a*0202/product/Epimmune Inc
Average 90 stars, based on 1 article reviews
mouse b cell lymphoma p815 transfected with hla-a*0202 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
easpsep mouse b cell isolation kit  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc easpsep mouse b cell isolation kit
Oxaliplatin (OXP) reduces the phosphorylation <t>of</t> <t>STAT3</t> and <t>RKIP</t> that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.
Easpsep Mouse B Cell Isolation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easpsep mouse b cell isolation kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easpsep mouse b cell isolation kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Oxaliplatin (OXP) reduces the phosphorylation of STAT3 and RKIP that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.

Journal: BMC Cancer

Article Title: RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

doi: 10.1186/1471-2407-13-463

Figure Lengend Snippet: Oxaliplatin (OXP) reduces the phosphorylation of STAT3 and RKIP that is induced by interleukin-6 (IL-6). Western blot analysis of: (A) the indicated proteins in HCT116 cells treated with IL-6 (40 ng/ml) for 1–6 h. (B) HCT116 cells treated with 300 μM OXP, IL-6 (40 ng/ml) in serum free medium or the combination for 16 h and analyzed for the indicated proteins via Western blot analysis. (C) Cell extracts were prepared after 18 h following treatment with OXP, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.20%); b) 5 μM STS (70.94%); 300 μM OXP (31.04%); d) IL-6 (4.01%); e) OXP + IL-6 (19.56%). STS is the positive control. The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice.

Article Snippet: The antibodies to STAT3 (sc-482), pRKIP (sc-32623), gp130 (SC-655) and actin (SC-1616) were purchased from Santa Cruz Biotechnology; STAT3 pY705 (9131S) and PARP (9542S) from Cell Signaling Technology; RKIP (07–137) and Histone 2AX (07–67) from Millipore, Milford, MA.

Techniques: Phospho-proteomics, Western Blot, Binding Assay, Control, Positive Control

Camptothecin (CPT) reduces phosphorylation of STAT3 and RKIP induced by interleukin-6 (IL-6). (A) Western blot analysis of: a dose-dependent reduction of STAT3 phosphorylation after IL-6 treatment then treated with 250–750 nM CPT; HCT116 cells treated with 250 nM CPT and 40 ng/ml IL-6 for 12 h. (B) The same co-treatment experiment as in (A) was repeated with HCT116 cells treated with 250 nM CPT and 40 ng/ml IL-6 for 12 h. Western blot analysis was performed to examine the protein levels of pRKIP, RKIP and actin. (C) Cell extracts were prepared after 18 h following treatment with CPT, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.48%); b) CPT (17.68%); c) IL-6 (0.64%); d) CPT + IL-6 (10.94%). The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice. (D) HCT116 cells were transfected with an IRF-1 reporter plasmid for STAT3 activation. After 48 h, the cells were washed and treated with 40 ng/ml IL-6, 250 nM CPT, or the combination. After 24 h, samples were harvested and washed twice before being lysed and combined with a luciferase assay reporter. The data is reported as the mean +/− s.d. of 2 independent experiments performed in triplicate. A paired t-test was performed to analyze the increase in STAT3 transcription of IL- 6 treated experimental samples when compared to vehicle (CTR): *IL-6, p < 0.000012; or decrease when comparing IL-6 to samples treated with **IL-6 and CPT, p < 0.0002.

Journal: BMC Cancer

Article Title: RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

doi: 10.1186/1471-2407-13-463

Figure Lengend Snippet: Camptothecin (CPT) reduces phosphorylation of STAT3 and RKIP induced by interleukin-6 (IL-6). (A) Western blot analysis of: a dose-dependent reduction of STAT3 phosphorylation after IL-6 treatment then treated with 250–750 nM CPT; HCT116 cells treated with 250 nM CPT and 40 ng/ml IL-6 for 12 h. (B) The same co-treatment experiment as in (A) was repeated with HCT116 cells treated with 250 nM CPT and 40 ng/ml IL-6 for 12 h. Western blot analysis was performed to examine the protein levels of pRKIP, RKIP and actin. (C) Cell extracts were prepared after 18 h following treatment with CPT, IL-6 or the combination for flow cytometric analysis to examine binding to 7-AAD and annexin-V (% Apoptosis). The % Apoptosis of each sample is indicated in the top right corner of every panel: a) untreated control cells (0.48%); b) CPT (17.68%); c) IL-6 (0.64%); d) CPT + IL-6 (10.94%). The figure is representative of part of 1 experiment performed in duplicate. The experiment was repeated twice. (D) HCT116 cells were transfected with an IRF-1 reporter plasmid for STAT3 activation. After 48 h, the cells were washed and treated with 40 ng/ml IL-6, 250 nM CPT, or the combination. After 24 h, samples were harvested and washed twice before being lysed and combined with a luciferase assay reporter. The data is reported as the mean +/− s.d. of 2 independent experiments performed in triplicate. A paired t-test was performed to analyze the increase in STAT3 transcription of IL- 6 treated experimental samples when compared to vehicle (CTR): *IL-6, p < 0.000012; or decrease when comparing IL-6 to samples treated with **IL-6 and CPT, p < 0.0002.

Article Snippet: The antibodies to STAT3 (sc-482), pRKIP (sc-32623), gp130 (SC-655) and actin (SC-1616) were purchased from Santa Cruz Biotechnology; STAT3 pY705 (9131S) and PARP (9542S) from Cell Signaling Technology; RKIP (07–137) and Histone 2AX (07–67) from Millipore, Milford, MA.

Techniques: Phospho-proteomics, Western Blot, Binding Assay, Control, Transfection, Plasmid Preparation, Activation Assay, Luciferase

Contingency analysis of cytoplasmic phosphorylated RKIP (c-pRKIP), nuclear phosphorylated RKIP (n-pRKIP) and nuclear STAT3 (n-STAT3) expression and tumor Grade and LVI status

Journal: BMC Cancer

Article Title: RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

doi: 10.1186/1471-2407-13-463

Figure Lengend Snippet: Contingency analysis of cytoplasmic phosphorylated RKIP (c-pRKIP), nuclear phosphorylated RKIP (n-pRKIP) and nuclear STAT3 (n-STAT3) expression and tumor Grade and LVI status

Article Snippet: The antibodies to STAT3 (sc-482), pRKIP (sc-32623), gp130 (SC-655) and actin (SC-1616) were purchased from Santa Cruz Biotechnology; STAT3 pY705 (9131S) and PARP (9542S) from Cell Signaling Technology; RKIP (07–137) and Histone 2AX (07–67) from Millipore, Milford, MA.

Techniques: Expressing